These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 16458976)

  • 1. Effectiveness and cost-effectiveness of antidepressant treatment in primary health care: a six-month randomised study comparing fluoxetine to imipramine.
    Serrano-Blanco A; Gabarron E; Garcia-Bayo I; Soler-Vila M; Caramés E; Peñarrubia-Maria MT; Pinto-Meza A; Haro JM;
    J Affect Disord; 2006 Apr; 91(2-3):153-63. PubMed ID: 16458976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluoxetine and imipramine: are there differences in cost-utility for depression in primary care?
    Serrano-Blanco A; Suárez D; Pinto-Meza A; Peñarrubia MT; Haro JM;
    J Eval Clin Pract; 2009 Feb; 15(1):195-203. PubMed ID: 19239602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomised controlled trial to compare the cost-effectiveness of tricyclic antidepressants, selective serotonin reuptake inhibitors and lofepramine.
    Peveler R; Kendrick T; Buxton M; Longworth L; Baldwin D; Moore M; Chatwin J; Goddard J; Thornett A; Smith H; Campbell M; Thompson C
    Health Technol Assess; 2005 May; 9(16):1-134, iii. PubMed ID: 15876362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of newer antidepressants compared with tricyclic antidepressants in managed care settings.
    Revicki DA; Brown RE; Keller MB; Gonzales J; Culpepper L; Hales RE
    J Clin Psychiatry; 1997 Feb; 58(2):47-58. PubMed ID: 9062373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TCAs or SSRIs as initial therapy for depression?
    Tyra JM; Greenawald MH
    J Fam Pract; 1999 Nov; 48(11):845-6. PubMed ID: 10907616
    [No Abstract]   [Full Text] [Related]  

  • 6. Study addresses question of preferred initial therapy for depression.
    Am J Health Syst Pharm; 1996 Sep; 53(17):1994. PubMed ID: 8870882
    [No Abstract]   [Full Text] [Related]  

  • 7. Initial antidepressant choice in primary care. Effectiveness and cost of fluoxetine vs tricyclic antidepressants.
    Simon GE; VonKorff M; Heiligenstein JH; Revicki DA; Grothaus L; Katon W; Wagner EH
    JAMA; 1996 Jun; 275(24):1897-902. PubMed ID: 8648870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multinational pharmacoeconomic evaluation of acute major depressive disorder (MDD): a comparison of cost-effectiveness between venlafaxine, SSRIs and TCAs.
    Doyle JJ; Casciano J; Arikian S; Tarride JE; Gonzalez MA; Casciano R
    Value Health; 2001; 4(1):16-31. PubMed ID: 11704969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modelling the cost effectiveness of antidepressant treatment in primary care.
    Revicki DA; Brown RE; Palmer W; Bakish D; Rosser WW; Anton SF; Feeny D
    Pharmacoeconomics; 1995 Dec; 8(6):524-40. PubMed ID: 10160081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost and effectiveness of venlafaxine extended-release and selective serotonin reuptake inhibitors in the acute phase of outpatient treatment for major depressive disorder.
    Trivedi MH; Wan GJ; Mallick R; Chen J; Casciano R; Geissler EC; Panish JM
    J Clin Psychopharmacol; 2004 Oct; 24(5):497-506. PubMed ID: 15349005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcomes of initial antidepressant drug choice in a "real world" randomized trial.
    Simon GE; Heiligenstein J; Revicki D; VonKorff M; Katon WJ; Ludman E; Grothaus L; Wagner E
    Arch Fam Med; 1999; 8(4):319-25. PubMed ID: 10418538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and economic comparison of sertraline and fluoxetine in the treatment of depression. A 6-month double-blind study in a primary-care setting in France.
    Boyer P; Danion JM; Bisserbe JC; Hotton JM; Troy S
    Pharmacoeconomics; 1998 Jan; 13(1 Pt 2):157-69. PubMed ID: 10184835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A placebo-controlled study of fluoxetine versus imipramine in the acute treatment of atypical depression.
    McGrath PJ; Stewart JW; Janal MN; Petkova E; Quitkin FM; Klein DF
    Am J Psychiatry; 2000 Mar; 157(3):344-50. PubMed ID: 10698808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomised controlled trial to determine the clinical effectiveness and cost-effectiveness of selective serotonin reuptake inhibitors plus supportive care, versus supportive care alone, for mild to moderate depression with somatic symptoms in primary care: the THREAD (THREshold for AntiDepressant response) study.
    Kendrick T; Chatwin J; Dowrick C; Tylee A; Morriss R; Peveler R; Leese M; McCrone P; Harris T; Moore M; Byng R; Brown G; Barthel S; Mander H; Ring A; Kelly V; Wallace V; Gabbay M; Craig T; Mann A
    Health Technol Assess; 2009 Apr; 13(22):iii-iv, ix-xi, 1-159. PubMed ID: 19401066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost effectiveness of venlafaxine compared with generic fluoxetine or generic amitriptyline in major depressive disorder in the UK.
    Lenox-Smith A; Greenstreet L; Burslem K; Knight C
    Clin Drug Investig; 2009; 29(3):173-84. PubMed ID: 19243210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antidepressant efficacy and safety of low-dose sertraline and standard-dose imipramine for the treatment of depression in older adults: results from a double-blind, randomized, controlled clinical trial.
    Forlenza OV; Almeida OP; Stoppe A; Hirata ES; Ferreira RCR
    Int Psychogeriatr; 2001 Mar; 13(1):75-84. PubMed ID: 11352337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tricyclic antidepressant and selective serotonin reuptake inhibitors antidepressant selection and health care costs in the naturalistic setting: a multivariate analysis.
    Hylan TR; Crown WH; Meneades L; Heiligenstein JH; Melfi CA; Croghan TW; Buesching DP
    J Affect Disord; 1998 Jan; 47(1-3):71-9. PubMed ID: 9476746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The treatment of major depressive disorders (MDD) in Thailand using escitalopram compared to fluoxetine and venlafaxine: a pharmacoeconomic evaluation.
    Kongsakon R; Bunchapattanasakda C
    J Med Assoc Thai; 2008 Jul; 91(7):1117-28. PubMed ID: 18839855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The study of the efficacy of fluoxetine versus tianeptine in the treatment of elderly depressed patients followed in general practice].
    Guelfi JD; Bouhassira M; Bonett-Perrin E; Lancrenon S
    Encephale; 1999; 25(3):265-70. PubMed ID: 10434153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sertraline versus imipramine treatment of comorbid panic disorder and major depressive disorder.
    Lepola U; Arató M; Zhu Y; Austin C
    J Clin Psychiatry; 2003 Jun; 64(6):654-62. PubMed ID: 12823079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.